First Time Loading...

Nemaura Medical Inc
NASDAQ:NMRD

Watchlist Manager
Nemaura Medical Inc Logo
Nemaura Medical Inc
NASDAQ:NMRD
Watchlist
Price: 0.043 USD 11.69% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

NMRD Price Targets Summary
Nemaura Medical Inc

There are no price targets for NMRD.
NMRD Lowest Forecast
Wall Street Target
Not Available
NMRD Average Forecast
Wall Street Target
Not Available
NMRD Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available

NMRD Last Price Targets
Nemaura Medical Inc

The latest public price target was made on Aug 19, 2022 by Unknown Analyst from H.C. Wainwright , who expects NMRD stock to rise by 18 505% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Unknown Analyst
H.C. Wainwright
8 USD
Upside 18 505%
1 year ago
Aug 19, 2022
HC Wainwright & Co. Maintains Buy on Nemaura Medical, Lowers Price Target to $8
Benzinga
Unknown Analyst
H.C. Wainwright
Price Target 8 USD
Upside/Downside 18 505%
View Source
Nemaura Medical Inc Competitors:
Price Targets
SMLR
Semler Scientific Inc
146% Upside
SYK
Stryker Corp
16% Upside
NYXH
Nyxoah SA
66% Upside
V
VREX
Varex Imaging Corp
82% Upside
SMLR
Semler Scientific Inc
146% Upside
SYK
Stryker Corp
16% Upside
NYXH
Nyxoah SA
66% Upside
V
VREX
Varex Imaging Corp
82% Upside
MEDI
Medistim ASA
10% Upside
CYRX
Cryoport Inc
17% Upside
CLPT
Clearpoint Neuro Inc
74% Upside
CODX
Co-Diagnostics Inc
111% Upside

Revenue
Forecast

Revenue Estimate
Nemaura Medical Inc

The compound annual growth rate of Nemaura Medical Inc's revenue for the next 2 years is 322%.

N/A
Past Growth
322%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Nemaura Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Nemaura Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
What are analyst estimates?

See Also

Summary
NMRD intrinsic value, competitors valuation, and company profile.
DCF Valuation
NMRD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NMRD stock valuation using valuation multiples.
Wall Street Estimates
NMRD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NMRD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NMRD's stock price target?
Not Available

NMRD doesn't have any price targets made by Wall Street professionals.

What is Nemaura Medical Inc's Revenue forecast?
Projected CAGR
322%

The compound annual growth rate of Nemaura Medical Inc's revenue for the next 2 years is 322%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.